Your browser doesn't support javascript.
loading
GINS4 suppresses ferroptosis by antagonizing p53 acetylation with Snail.
Chen, Ling; Cai, Qidong; Yang, Rui; Wang, Haiyan; Ling, Huli; Li, Tiansheng; Liu, Na; Wang, Zuli; Sun, Jingyue; Tao, Tania; Shi, Ying; Cao, Ya; Wang, Xiang; Xiao, Desheng; Liu, Shuang; Tao, Yongguang.
Afiliação
  • Chen L; Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha Hunan 410031, China.
  • Cai Q; Department of Pathology, Xiangya Hospital, Central South University, Changsha Hunan 410008, China.
  • Yang R; Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, National Health Commission Key Laboratory of Carcinogenesis, Cancer Research Institute, Central South University, Changsha Hunan 410078, China.
  • Wang H; Department of Thoracic Surgery, Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, Second Xiangya Hospital, Central South University, Changsha Hunan 410011, China.
  • Ling H; Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha Hunan 410031, China.
  • Li T; Department of Pathology, Xiangya Hospital, Central South University, Changsha Hunan 410008, China.
  • Liu N; Department of Pathology, School of Basic Medicine, Central South University, Changsha Hunan 410013, China.
  • Wang Z; Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha Hunan 410031, China.
  • Sun J; Department of Pathology, Xiangya Hospital, Central South University, Changsha Hunan 410008, China.
  • Tao T; Department of Pathology, School of Basic Medicine, Central South University, Changsha Hunan 410013, China.
  • Shi Y; Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha Hunan 410031, China.
  • Cao Y; Department of Pathology, Xiangya Hospital, Central South University, Changsha Hunan 410008, China.
  • Wang X; Department of Pathology, School of Basic Medicine, Central South University, Changsha Hunan 410013, China.
  • Xiao D; Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha Hunan 410031, China.
  • Liu S; Department of Pathology, Xiangya Hospital, Central South University, Changsha Hunan 410008, China.
  • Tao Y; Department of Pathology, School of Basic Medicine, Central South University, Changsha Hunan 410013, China.
Proc Natl Acad Sci U S A ; 120(15): e2219585120, 2023 04 11.
Article em En | MEDLINE | ID: mdl-37018198
Ferroptosis is an iron-dependent oxidative, nonapoptotic form of regulated cell death caused by the destruction of redox homeostasis. Recent studies have uncovered complex cellular networks that regulate ferroptosis. GINS4 is a promoter of eukaryotic G1/S-cell cycle as a regulator of initiation and elongation of DNA replication, but little is known about its impact on ferroptosis. Here, we found that GINS4 was involved in the regulation of ferroptosis in lung adenocarcinoma (LUAD). CRISPR/Cas9-mediated GINS4 KO facilitated ferroptosis. Interestingly, depletion of GINS4 could effectively induce G1, G1/S, S, and G2/M cells to ferroptosis, especially for G2/M cells. Mechanistically, GINS4 suppressed p53 stability through activating Snail that antagonized the acetylation of p53, and p53 lysine residue 351 (K351 for human p53) was the key site for GINS4-suppressed p53-mediated ferroptosis. Together, our data demonstrate that GINS4 is a potential oncogene in LUAD that functions to destabilize p53 and then inhibits ferroptosis, providing a potential therapeutic target for LUAD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ferroptose Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ferroptose Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article